Clinical Trials Browser

Cervical Esophagus Adenocarcinoma

Carcinoma, Transitional Cell

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Pancreatic Neoplasms, Neoplasms, Basal Cell

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Esophageal Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Small Bowel Adenocarcinoma

Stomach Neoplasms

Locally Advanced Rectal Cancer

Pancreatic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Pancreatic cancer, adult, Pancreatic Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Gastrointestinal Neoplasms

Adenocarcinoma

Stomach Neoplasms

Locally Recurrent Rectal Cancer

Colonic Neoplasms

Adenocarcinoma

Colorectal Neoplasms

Colorectal Neoplasms

Advanced Solid Tumors

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Colorectal Cancer Metastatic

Colonic Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Carcinoma, Hepatocellular

Clinical Trials

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

LAP100

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

PANGEA

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

FRUITFUL

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

TRIBE-C

PANCREAS

FOBEAR

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

SMART TNT

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

CAPRI-3 GOIM

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

PANC

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

CEIL

AIO-KRK-0418

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

AtezoTRIBE2

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

I-FLOAT

BIG

Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)

The Sagittarius Trial

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Trial of ProAgio in Advanced/Metastatic Colorectal Cancer

OPTICAL-2

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

OSCAR

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

SAIB

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

NICER

PANThEON

HAICI

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy